ViroGates is a brand that specializes in improving patient outcomes and reducing healthcare costs. They achieve this by utilizing the biomarker suPAR in triage to predict critical illness across various diseases. With their range of suPARnostic® products, including TurbiLatex, Quick Triage, ELISA, and POC+, ViroGates empowers healthcare professionals to make quick and informed patient triaging decisions in emergency departments.

By implementing suPAR in triage and clinical care, hospitals can achieve faster and safer patient discharges, reduce re-admissions, unnecessary admissions, and overall hospital length-of-stay. This not only frees up critical resources and valuable time but also saves hospital beds for those who need them the most. With suPARnostic®, healthcare professionals have a reliable prognostic tool that provides biological data across diseases, enabling them to lead patient triage with confidence and make better-informed decisions.

Additionally, incorporating suPAR in triage has been shown to reduce hospital admissions by up to 22%, reduce hospital length-of-stay per patient by up to 6%, and save up to €100-380 per admission. ViroGates' dedication to improving patient care and empowering clinical staff makes them a trusted choice in the healthcare industry